Nemaura Medical Patents – Key Insights and Stats

Nemaura Medical has a total of 38 patents globally, out of which 19 have been granted. Of these 38 patents, more than 63% patents are active. The UK is where Nemaura Medical has filed the maximum number of patents, followed by United States of America and Japan, it has generated an annual revenue of $3.53 billion in the year 2021. Parallelly, China seems to be the main focused R&D centre of Nemaura Medical.

Nemaura Medical was founded in the year 2013 by Dr Faz Chowdhury. Nemaura is a UK based Medical Technology Company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT. As of August 2022, Nemaura Medical has a market cap of $50.76 Million.

Do read about some of the most popular patents of Nemaura Medical which have been covered by us in this article and also you can find Nemaura Medical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Nemaura Medical patent portfolio.

How many patents does the founder and the CEO of Nemaura Medical have?

The founder & CEO, Dr Faz Chowdhury, has 0 patents.

How many patents does Nemaura Medical have?

Nemaura Medical has a total of 38 patents globally. These patents belong to 14 unique patent families. Out of 38 patents, 24 patents are active.

How Many Patents did Nemaura Medical File Every Year?

Nemaura Medical Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantNemaura Medical Applications FiledNemaura Medical Patents Granted
20112
201211
201311
20142
201532
201623
20174
201824
201981
202011
202113
2022

How many Nemaura Medical patents are Alive/Dead?

Nemaura Medical Patent Portfolio

How Many Patents did Nemaura Medical File in Different Countries?

Nemaura Medical Worldwide Patent Filing

Countries in which Nemaura Medical Filed Patents

CountryPatents
United Kingdom11
United States Of America5
Japan4
Europe3
Australia2
Canada2
Germany2
United Arab Emirates1
Brazil1
China1
Poland1
Spain1
Hong Kong (S.A.R.)1
India1

Where are Research Centres of Nemaura Medical Patents Located?

R&D Centres of Nemaura Medical

Most Cited Nemaura Medical Patents

US20120323097A9 is the most popular patent in the Nemaura Medical portfolio. It has received 26 citations so far from companies like Zyomed and Biolinq. The invention relates to patches for applying to the skin of a patient, whereby constituents of fluids in the skin for analysis can be withdrawn through the skin by the technique of reverse iontophoresis.

The company created SugarBEAT, a disposable skin patch that adheres to the body using a soft silicone gel that is not irritant. The rechargeable transmitter that the skin patch links to measures blood sugar levels and sends the information to a mobile app every five minutes.

List of Nemaura Medical Patents

Nemaura PatentsTitle
US10092224B2Cumulative Measurement Of An Analyte
US20220054767A1Skin Preparation Patches
US20220023229A1Attachment Of Membranes For Transdermal Devices
US20180197637A1Consumer Wellbeing Algorithm
US20120323097A9Patch For Reverse Iontophoresis
EP2852323B1Cumulative Measurement Of An Analyte
EP3893729A1Attachment Of Membranes For Transdermal Devices
EP3890647A1Skin Preparation Patches
CN104470428BCumulative Measurement Of Analyte
WO2020120511A1Attachment Of Membranes For Transdermal Devices
WO2020115465A1Skin Preparation Patches
GB2579575BSkin Preparation Patches
GB2579651BAttachment Of Membranes For Transdermal Devices
GB2497726BDetermining The Volume Of A Liquid In A Reverse Iontophoresis Chamber
GB2502287BCumulative Measurement Of An Analyte
GB202117714D0Davices For Measuring Markers For Metabolic Health
GB202003457D0Pre-Treating Skin For Extracting And Measuring The Concentration Of Substance In A Subject
GB201915625D0Calibration Of Analyte Sensors
GB201603668D0Method For Determining Concentration Of Substances In A Subject
GB201508754D0Method For Determining Concentration Of Substances In A Subject
GB201504015D0Liquid Containing Skin Patches
GB201305352D0Connection Means For Medical Sensor And Device
DE602013011114T2Cumulative Measurement Of An Analyte
DE602009007570T2Pavement For Reverse Iontophoresis
PL2852323T3Cumulative Measurement Of An Analyte
ES2614755T3Cumulative Measurement Of An Analyte
JP6538554B2Cumulative Measurement Of Analytes
JP6294850B2Patch For Reverse Iontophoresis And Method Of Operating The Patch
JP5794914B2Patch For Reverse Ion Tophoresis
JP2022518967AConnectors Of Membranes For Transdermal Devices
CA2873616CCumulative Measurement Of An Analyte
CA2766331A1Patches For Reverse Iontophoresis
AU2013264992B2Cumulative Measurement Of An Analyte
AU2009265416B2Patches For Reverse Iontophoresis
BR112014028850B1Method Of Monitoring Of An Analyte Level In A Subject
AE1273BCumulative Measurement Of An Analyte
IN2847KOLNP2014ACumulative Measurement Of An Analyte
HK1156199A1Patches For Reverse Iontophoresis

EXCLUSIVE INSIGHTS COMING SOON!

What are Nemaura Medical’s key innovation segments?

What Technologies are Covered by Nemaura Medical?

This image has an empty alt attribute; its file name is Tech-Area-Blur-22-1024x576.webp

The chart below distributes patents filed by Nemaura Medical in different countries on the basis of the technology protected in patents. It also represents the markets where Nemaura Medical thinks it’s important to protect particular technology inventions.

This image has an empty alt attribute; its file name is Tech-Protected-blur-22-1024x576.jpg

R&D Focus: How Nemaura Medical’s search focus changed over the years?

This image has an empty alt attribute; its file name is Technology-Through-the-year-Blur-22-1024x576.jpg

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Nemaura Medical?

Updated on August 22, 2022

Was this article helpful?

Leave a Comment